Are nanoplastics hazardous? The way forward to overcome the uncertainties of risk assessment: 24 February 2022; Read the latest Nanopinion guest column from Dr. Anita Jemec Kokalj and Dr. Dana Kühnel about defining the criteria to evaluate which properties of nanoplastics should be reported in future studies to decrease uncertainties in the risk assessment of nanoplastics.

3 February 2022 Update of the Appendix for nanoforms published

ECHA has published an update to the Appendix for nanoforms applicable to the Guidance on Registration and Substance Identification (v.2.0).

The main changes include additional guidance on the joint submission of data, clarifications regarding the need for one dataset per nanoform/set of nanoforms and information on the registration of sets of nanoforms versus single nanoforms.
18 January 2022 What does “Graphene” really look like and why is it not ‘carbon nanotubes’

Read the latest Nanopinion guest column from Dr. Alberto Bianco, Dr. Maurizio Prato and Dr. Kostas Kostarelos, from Graphene Flagship, about graphene and why it’s not the same as carbon nanotubes.
21 December 2021 ACEnano: Goobdye, Hello

Read the latest Nanopinion guest column from Dr. Eugenia Valsami-Jones about ACEnano, a Horizon2020 project which has recently completed its 4.5-year course. The main goal of the project was to strengthen clarity into nanomaterial risk assessment by a tiered approach to nanomaterials physiochemical characterisation.

Nanomaterials and health

Are substances in nanoforms more dangerous than they are in their normal size? Some are and some are not. Just like any other chemical substance, nanomaterials have to be assessed separately.

Fighting cancer using nanotechnology

Nanomaterials are not only used in consumer products, but also in new and innovative medical treatments. Research has shown that nanoparticles can be used to damage and even destroy cancer cells from within.